Correspondence
Profile of Specific Antibodies to the SARS-Associated Coronavirus
N Engl J Med 2003; 349:508-509July 31, 2003
- Article
To the Editor:
A novel coronavirus called the severe acute respiratory syndrome (SARS)–associated coronavirus (CoV) has been identified as the causal agent of SARS.1-3 To understand the humoral immunity to this virus, we studied the profile of IgM and IgG antibody responses to SARS-CoV. IgM and IgG antibodies were analyzed by an indirect enzyme-linked immunosorbent assay in 20 patients with SARS from week 1 of their illness to week 12 and in 103 healthy contacts.
All 20 patients tested negative for IgM and IgG at week 1 after the onset of symptoms. Of these patients, 16 tested positive for IgM and 17 tested positive for IgG at week 2 (Figure 1Figure 1
Changing Titers of IgM and IgG Antibodies to the SARS-Associated Coronavirus from the Onset of Illness through the Convalescent Phase.). All 20 patients were IgG-positive after week 3 and continued to have high levels of IgG up to three months after the onset of symptoms. The IgG titers were low at the beginning of week 2 (mean, 1:40, with the cutoff for a positive result being 1:10), increased to an average of 1:256 at week 3, and peaked at 1:640 at week 12. The IgM titers peaked during the acute or early convalescent phase and then declined with IgM disappearing by the end of week 12. All 103 healthy contacts tested negative for IgM and IgG.Our results suggest that 100 percent of patients had antibody responses to SARS-CoV during the convalescent phase. The SARS-specific IgG antibody persisted for a long time, but the SARS-specific IgM remained measurable for a much shorter period, suggesting that IgG antibody to SARS-CoV may represent the primary humoral immune response protecting patients against SARS. The profile of antibodies against SARS-CoV was consistent with common findings with regard to acute viral infectious diseases such as hepatitis A.4 The profile of anti-SARS antibodies may be helpful in the diagnosis and in epidemiologic surveys. The presence of high titers of IgG antibody to SARS-CoV in the patients at the convalescent stage also suggests that a live attenuated or inactivated vaccine for active immunization and a concentrated human SARS-specific IgG antibody for passive immunization could be developed for the treatment of SARS.
4 ReferencesGang Li, M.D., Ph.D.
Xuejuan Chen
Anlong Xu, Ph.D.
Sun Yat Sen University, Guangzhou 510275, China
ligangzh@pub.guangzhou. gd. cn 1
Ksiazek TG ,Erdman D ,Goldsmith CS , et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-1966
Full Text | Web of Science | Medline2
Drosten C ,Gunther S ,Preiser W , et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-1976
Full Text | Web of Science | Medline3
Poutanen SM ,Low DE ,Henry B , et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348:1995-2005
Full Text | Web of Science | Medline4
Kawai H, Feinstone SM. Acute viral hepatitis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Vol. 1. Philadelphia: Churchill Livingstone, 2000:1279-97.
- Citing Articles (36)
Citing Articles
1
Wei Liu, Xiao-Na Han, Fang Tang, Gerard J. J. M. Borsboom, Hong Yang, Wu-Chun Cao, Sake J. de Vlas. (2009) No evidence of over-reporting of SARS in mainland China. Tropical Medicine & International Health 14, 46-51
CrossRef2
Shunsuke Kohyama, Satoshi Ohno, Tatsuya Suda, Maiko Taneichi, Shoichi Yokoyama, Masahito Mori, Akiharu Kobayashi, Hidenori Hayashi, Tetsuya Uchida, Masanori Matsui. (2009) Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a. Antiviral Research 84:2, 168-177
CrossRef3
Satoshi Ohno, Shunsuke Kohyama, Maiko Taneichi, Osamu Moriya, Hidenori Hayashi, Hiroshi Oda, Masahito Mori, Akiharu Kobayashi, Toshitaka Akatsuka, Tetsuya Uchida, Masanori Matsui. (2009) Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice. Vaccine 27:29, 3912-3920
CrossRef4
Yu-ya Mitsuki, Kazuo Ohnishi, Hirotaka Takagi, Masamichi Oshima, Takuya Yamamoto, Fuminori Mizukoshi, Kazutaka Terahara, Kazuo Kobayashi, Naoki Yamamoto, Shoji Yamaoka, Yasuko Tsunetsugu-Yokota. (2008) A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV. Microbes and Infection 10:8, 908-915
CrossRef5
Chung-Hua Hsu, Kung-Chang Hwang, Chung-Liang Chao, Steve G. N. Chang, Mei-Shang Ho, Jaung-Geng Lin, Hen-Hong Chang, Shung-Te Kao, Yi-Ming Chen, Pesus Chou. (2008) An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-Like Infectious Diseases in 2003: A Randomized, Double-Blind, and Controlled Pilot Study. Evidence-Based Complementary and Alternative Medicine 5:3, 355-362
CrossRef6
Li-Tao Yang, Hui Peng, Zhao-Ling Zhu, Gang Li, Zi-Tong Huang, Zhi-Xin Zhao, Richard A. Koup, Robert T. Bailer, Chang-You Wu. (2006) Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients. Clinical Immunology 120:2, 171-178
CrossRef7
Yasuko Tsunetsugu-Yokota, Kazuo Ohnishi, Toshitada Takemori. (2006) Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine. Reviews in Medical Virology 16:2, 117-131
CrossRef8
Nelson Lee, P.K.S. Chan, Margaret Ip, Eric Wong, Jenny Ho, Catherine Ho, C.S. Cockram, David S. Hui. (2006) Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome. Journal of Clinical Virology 35:2, 179-184
CrossRef9
Linqi Zhang, Fengwen Zhang, Wenjie Yu, Tian He, Jian Yu, Christopher E. Yi, Lei Ba, Wenhui Li, Michael Farzan, Zhiwei Chen, Kwok-Yung Yuen, David Ho. (2006) Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. Journal of Medical Virology 78:1, 1-8
CrossRef10
Hongying MO, Guangqiao ZENG, Xiaolan REN, Hui LI, Changwen KE, Yaxia TAN, Chaoda CAI, Kefang LAI, Rongchang CHEN, Moira CHAN-YEUNG, Nanshan ZHONG. (2006) Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology 11:1, 49-53
CrossRef11
Jan ter Meulen, Edward N. van den Brink, Leo L. M. Poon, Wilfred E. Marissen, Cynthia S. W. Leung, Freek Cox, Chung Y. Cheung, Arjen Q. Bakker, Johannes A. Bogaards, Els van Deventer, Wolfgang Preiser, Hans Wilhelm Doerr, Vincent T. Chow, John de Kruif, Joseph S. M. Peiris, Jaap Goudsmit. (2006) Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants. PLoS Medicine 3:7, e237
CrossRef12
John M. Nicholls, Jagdish Butany, Leo L. M. Poon, Kwok H. Chan, Swan Lip Beh, Susan Poutanen, J. S. Malik Peiris, Maria Wong. (2006) Time Course and Cellular Localization of SARS-CoV Nucleoprotein and RNA in Lungs from Fatal Cases of SARS. PLoS Medicine 3:2, e27
CrossRef13
Jai-hai LU, Zhong-min GUO, Wen-yu HAN, Guo-ling WANG, Ding-mei ZHANG, Yi-fei WANG, Sheng-yun SUN, Qin-he YANG, Huan-ying ZHENG, Bing L WONG, Nan-shan ZHONG. (2005) Preparation and development of equine hyperimmune globulin F(ab')2 against severe acute respiratory syndrome coronavirus1. Acta Pharmacologica Sinica 26:12, 1479-1484
CrossRef14
Yong-Hua Li, Jie Li, Xue-En Liu, Ling Wang, Tong Li, Yi-Hua Zhou, Hui Zhuang. (2005) Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum: Comparison with results of other viral markers. Journal of Virological Methods 130:1-2, 45-50
CrossRef15
Jian-San Zhang, Jiang-Ting Chen, Yu-Xuan Liu, Zhen-Shan Zhang, Hong Gao, Yan Liu, Xu Wang, Ye Ning, Yu-Fen Liu, Qiang Gao, Jian-Guo Xu, Chuan Qin, Xiao-Ping Dong, Wei-Dong Yin. (2005) A serological survey on neutralizing antibody titer of SARS convalescent sera. Journal of Medical Virology 77:2, 147-150
CrossRef16
Ran-Yi Liu, Li-Zhi Wu, Bi-Jun Huang, Jia-Ling Huang, Yan-Ling Zhang, Miao-La Ke, Jun-Mei Wang, Wei-Ping Tan, Ru-Hua Zhang, Han-Kui Chen, Yi-Xin Zeng, Wenlin Huang. (2005) Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats. Virus Research 112:1-2, 24-31
CrossRef17
Jinzhu Duan, Xiyun Yan, Xueming Guo, Wuchun Cao, Wei Han, Cai Qi, Jing Feng, Dongling Yang, Guangxia Gao, Gang Jin. (2005) A human SARS-CoV neutralizing antibody against epitope on S2 protein. Biochemical and Biophysical Research Communications 333:1, 186-193
CrossRef18
Shixia Wang, Pavlo Sakhatskyy, Te-Hui W. Chou, Shan Lu. (2005) Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV). Journal of Immunological Methods 301:1-2, 21-30
CrossRef19
Maofeng Qiu, Yuling Shi, Zhaobiao Guo, Zeliang Chen, Rongqiao He, Runsheng Chen, Dongsheng Zhou, Erhei Dai, Xiaoyi Wang, Bingyin Si, Yajun Song, Jingxiang Li, Ling Yang, Jin Wang, Hongxia Wang, Xin Pang, Junhui Zhai, Zongmin Du, Ying Liu, Yong Zhang, Linhai Li, Jian Wang, Bing Sun, Ruifu Yang. (2005) Antibody responses to individual proteins of SARS coronavirus and their neutralization activities. Microbes and Infection 7:5-6, 882-889
CrossRef20
Jia-Ling Huang, Jian Huang, Zhao-Hui Duan, Jing Wei, Jun Min, Xiao-Hong Luo, Jian-Guo Li, Wei-Ping Tan, Li-Zhi Wu, Ran-Yi Liu, Yan Li, Jing Shao, Bi-Jun Huang, Yi-Xin Zeng, Wenlin Huang. (2005) Th2 predominance and CD8+ memory T cell depletion in patients with severe acute respiratory syndrome. Microbes and Infection 7:3, 427-436
CrossRef21
D. Xu, Z. Zhang, L. Jin, F. Chu, Y. Mao, H. Wang, M. Liu, M. Wang, L. Zhang, G. F. Gao, F. S. Wang. (2005) Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. European Journal of Clinical Microbiology & Infectious Diseases 24:3, 165-171
CrossRef22
Danuta M. Skowronski, Caroline Astell, Robert C. Brunham, Donald E. Low, Martin Petric, Rachel L. Roper, Pierre J. Talbot, Theresa Tam, Lorne Babiuk. (2005) Severe Acute Respiratory Syndrome (SARS): A Year in Review. Annual Review of Medicine 56:1, 357-381
CrossRef23
Michael J. Gubbins, Frank A. Plummer, Xin Y. Yuan, Darrell Johnstone, Mike Drebot, Maya Andonova, Anton Andonov, Jody D. Berry. (2005) Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus. Molecular Immunology 42:1, 125-136
CrossRef24
C Drosten, KH Chan, LLM Poon. 2005. Viral Diagnosis of SARS. , 64-71.
CrossRef25
P.-R. Hsueh, L.-M. Huang, P.-J. Chen, C.-L. Kao, P.-C. Yang. (2004) Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clinical Microbiology and Infection 10:12, 1062-1066
CrossRef26
C.W. Leung, W.K. Chiu. (2004) Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children. Paediatric Respiratory Reviews 5:4, 275-288
CrossRef27
LLM Poon, Y Guan, JM Nicholls, KY Yuen, JSM Peiris. (2004) The aetiology, origins, and diagnosis of severe acute respiratory syndrome. The Lancet Infectious Diseases 4:11, 663-671
CrossRef28
Patrick Chow-In Ko, Wen-Jone Chen, Matthew Huei-Ming Ma, Wen-Chu Chiang, Chan-Ping Su, Chien-Hua Huang, Tsung-Chien Lu, Fuh-Yuan Shih, Fang-Yue Lin. (2004) Emergency Medical Services Utilization during an Outbreak of Severe Acute Respiratory Syndrome (SARS) and the Incidence of SARS-associated Coronavirus Infection among Emergency Medical Technicians. Academic Emergency Medicine 11:9, 903-911
CrossRef29
Jody D Berry, Steven Jones, Michael A Drebot, Anton Andonov, Marta Sabara, Xin Y Yuan, Hana Weingartl, Lisa Fernando, Peter Marszal, Jason Gren, Brigitte Nicolas, Maya Andonova, Francesca Ranada, Michael J Gubbins, T.Blake Ball, Paul Kitching, Yan Li, Amin Kabani, Frank Plummer. (2004) Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus. Journal of Virological Methods 120:1, 87-96
CrossRef30
M. D. Christian, S. M. Poutanen, M. R. Loutfy, M. P. Muller, D. E. Low. (2004) Severe Acute Respiratory Syndrome. Clinical Infectious Diseases 38:10, 1420-1427
CrossRef31
Yi-Hua Zhou. (2004) Prevalence of non-pneumonic infections with SARS-correlated virus. The Lancet 363:9423, 1825-1826
CrossRef32
Yi‐Hua Zhou, Zhaochun Chen. (2004) Is the Immune System Impaired in Patients with Severe Acute Respiratory Syndrome?. Clinical Infectious Diseases 38:6, 921-922
CrossRef33
Fanya Zeng, Ken Yan Ching Chow, Chung Chau Hon, Ka Man Law, Chi Wai Yip, Kwok Hung Chan, Joseph S.Malik Peiris, Frederick Chi Ching Leung. (2004) Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments. Biochemical and Biophysical Research Communications 315:4, 1134-1139
CrossRef34
Mau-Sun Chang, Yen-Ta Lu, Shin-Tsung Ho, Chao-Chih Wu, Tsai-Yin Wei, Chia-Ju Chen, Yun-Ting Hsu, Po-Chen Chu, Ching-Hsin Chen, Jien-Ming Chu, Ya-Lin Jan, Chia-Chien Hung, Chi-Chen Fan, Yuh-Cheng Yang. (2004) Antibody detection of SARS-CoV spike and nucleocapsid protein. Biochemical and Biophysical Research Communications 314:4, 931-936
CrossRef35
(2004) Biomedical vignette. Journal of Biomedical Science 11:1, 1-3
CrossRef36
A. Berger, Ch. Drosten, H.W. Doerr, M. Stürmer, W. Preiser. (2004) Severe acute respiratory syndrome (SARS)—paradigm of an emerging viral infection. Journal of Clinical Virology 29:1, 13-22
CrossRef
